Stockscreener 앱 받기
0.405
3.74%
0.0146
China Sxt Pharmaceuticals Inc 주식(SXTC)의 최신 뉴스
SXTC stock hits 52-week low at $0.43 amid sharp annual decline - Investing.com Australia
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
SXTC stock touches 52-week low at $0.52 amid market challenges - Investing.com India
SXTC stock touches 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
In the Green: China SXT Pharmaceuticals Inc (SXTC) Closes at 0.63, Up/Down 12.64 from Previous Day - The Dwinnex
SXTC’s Stock Market Adventure: -84.07% YTD Growth Amidst Volatility - The InvestChronicle
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.05% - MSN
Visteon to Announce Third Quarter 2024 Results - The Manila Times
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency - The Manila Times
China SXT Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
SXTC’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Insider’s View: Deciphering China SXT Pharmaceuticals Inc (SXTC)’s Financial Health Through Ratios - The Dwinnex
SXTC’s Market Whiplash: -83.70% YTD Decline, -22.51% Plunge in 30 Days - The InvestChronicle
How does SXTC’s price to cash per share ratio compare in the market? - US Post News
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Sees Large Increase in Short Interest - Defense World
China SXT Pharmaceuticals (NASDAQ:SXTC) Stock Quotes, Forecast and News Summary - Benzinga
China's First Generic Version of AstraZeneca's Xigduo XR Diabetes Pill Gets Green Light - Yicai Global
SIMPLY SOLVENTLESS PROVIDES Q3 2024 GUIDANCE INCLUDING RECORD PROJECTED QUARTERLY REVENUE AND EIGHTH STRAIGHT QUARTER OF NET INCOME PROFIT, AND ANNOUNCES UPCOMING PRODUCT LAUNCHES – Company A - Financial Times
China SXT Pharmaceuticals Inc (SXTC)’s results reveal risk - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
SXTC stock touches 52-week low at $0.6 amid sharp annual decline - Investing.com India
Closing Figures Unveiled: China SXT Pharmaceuticals Inc (SXTC) Drop -8.88, Closes at 0.63 - The Dwinnex
SXTC stock plunges to 52-week low of $0.75 amid market challenges - Investing.com Australia
SXTC’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Resilience: China SXT Pharmaceuticals Inc (SXTC) Finishes Weak at 0.94, Down -6.00 - The Dwinnex
China SXT Pharma stock hits 52-week low at $0.92 amid downturn - Investing.com India
SXTC stock hits 52-week low at $0.93 amid sharp annual decline - Investing.com India
Navigating SXTC Stock: China SXT Pharmaceuticals Inc Journey - The InvestChronicle
Did China SXT Pharmaceuticals Inc (SXTC) perform well in the last session? - US Post News
China SXT Pharmaceuticals Inc (SXTC) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Balance Sheet Insights: China SXT Pharmaceuticals Inc (SXTC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
China SXT Pharmaceuticals Inc (SXTC) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Down 25.1% in June - Defense World
China SXT Pharmaceuticals Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Market Watch Highlights: China SXT Pharmaceuticals Inc (SXTC) Ends on an Downturn Note at 1.06 - The Dwinnex
Examining China SXT Pharmaceuticals Inc (SXTC) stock is warranted - US Post News
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment - Quantisnow
China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Update - Defense World
Successful Portfolios LLC Lowers Stock Holdings in The Southern Company (NYSE:SO) - Defense World
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split - Quantisnow
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.1 Million Underwritten Public Offering of Ordinary Shares ... - Quantisnow
China SXT Pharmaceuticals Inc Inc. (SXTC) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
A closer look at China SXT Pharmaceuticals Inc (SXTC) is warranted – US Post News - US Post News
Deeper Dive: Understanding China SXT Pharmaceuticals Inc (SXTC) Through its Various Ratios – DWinneX - The Dwinnex
SXTC’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
China SXT Pharmaceuticals Inc (SXTC) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Daily Market Movement: China SXT Pharmaceuticals Inc (SXTC) Sees a 0.94 Increase, Closing at 1.07 – DWinneX - The Dwinnex
12 Health Care Stocks Moving In Monday's Pre-Market SessionAkanda (NASDAQ:AKAN) - Benzinga
China SXT Pharmaceuticals Announces New Investment DealTipRanks.com - TipRanks
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Markets Insider
0.83%
1.03%
자본화:
|
볼륨(24시간):